Items tagged with Access
Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments (post with simple image)
Médecins Sans Frontières released the 4th edition of its report DR-TB Drugs Under the Microscope. The report analyzes the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis.
WHO: Developing countries need smart IP systems for local medicines production (post with simple image)
The World Health Organization has released a report on the role of intellectual property in local production of medicines in developing countries. According to the report, the way countries design their intellectual property system is key in the development of local innovation and production. However, health outcomes will depend on the accessibility and affordability of good-quality essential medicines.
Lives on the Edge: Time to align medical research and development with people’s health needs (post with simple image)
Médecins Sans Frontières (MSF) released a report that outlines shortcomings of the current system for new drug development. The report highlights resulting access barriers and proposes policy solutions.
Stop TB Partnership Global Drug Facility announces 70 percent price reduction for linezolid (post with simple image)
Linezolid is a critical component of regimens used to treat multidrug-resistant tuberculosis (MDR-TB). The GDF-negotiated price reduction is projected to save up to US$ 30 million over the next three years, helping to further improve equitable access to MDR-TB treatment.
Stop TB Partnership launches seven key population briefs (post with simple image)
The Stop TB Partnership released a series of briefs on TB key populations recognizing that reaching everyone with services, diagnostics, treatment and care is essential to ending the TB epidemic. The briefs focus on children, miners, mobile populations, urban populations, prisoners, rural populations and people who use drugs.
Global Fund and Stop TB Partnership sign Memorandum of Understanding with Global Drug Facility (post with simple image)
The Stop TB Partnership signed a Memorandum of Understanding with the Global Fund to Fight AIDS, Tuberculosis and Malaria to optimize access to TB health products and pharmaceutical services in countries receiving Global Fund financing for TB.
Call to Action to accelerate access to DR-TB drugs: 2016 update (post with simple image)
The update informs about the general progress in the introduction of bedaquiline and delamanid in TB programs worldwide and reports on the requests made in the Call to Action issued in March 2015.
Advocates call for the Ministry of Health in Cote d’Ivoire to adopt new TB test (post with simple image)
TB advocates urge the Ministry of Health in Cote d’Ivoire to introduce a new, simple, and rapid TB test, TB LAM, which detects TB antigens in urine, and is an important tool for detecting TB in certain populations living with HIV.
Lancet Series on HIV and related infections in prisoners (post with simple image)
Mass imprisonment of drug users driving global epidemics of HIV, hepatitis, and tuberculosis.
Commitment on investment in access to essential medicines signed at UNCTAD14 (post with simple image)
NAIROBI, Kenya (IP-Watch) – A commitment signed this week to facilitate investment in Africa’s pharmaceutical industry is expected to boost the sector’s production and make available essential medicines for millions of needy people.
Page 51 of 60 · Total posts: 0←First 50 51 52 Last→